Skip to main content
MCHX
NASDAQ Technology

Marchex Seeks Shareholder Approval for Archenia Acquisition, Discloses Financial Projections

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
8
Price
$1.62
Mkt Cap
$71.771M
52W Low
$1.322
52W High
$2.31
Market data snapshot near publication time

Summary

Marchex is seeking shareholder approval for its acquisition of Archenia, a related-party transaction valued at up to $16.52 million, which includes convertible notes and potential earn-out shares.


Key Events

  • Acquisition Details

    Marchex seeks approval to acquire Archenia, a performance-based marketing technology company, for up to $16.52 million. The consideration includes $10 million in convertible promissory notes (convertible at $1.80 per share) and up to 4 million Class B common shares as earn-out consideration.

  • Related-Party Transaction

    The sellers of Archenia include Marchex's Chairman, Russell C. Horowitz, and Vice Chairman, Michael Arends. This related-party nature requires approval by a "Majority of the Minority Vote" from disinterested shareholders.

  • Potential Dilution

    The earn-out consideration could result in the issuance of up to 4 million Class B shares, representing approximately 10% of current Class B shares outstanding, which is a notable dilutive event.

  • Strategic Rationale

    The acquisition aims to integrate Archenia's AI-verified customer qualification and acquisition capabilities with Marchex's existing AI-driven conversation intelligence solutions, expanding product offerings and market opportunities.


Analysis

This preliminary proxy statement details the proposed acquisition of Archenia, Inc. for up to $16.52 million, consisting of convertible notes and potential earn-out shares. The transaction is significant, representing approximately 23% of Marchex's market capitalization, and involves related parties (Marchex's Chairman and Vice Chairman are sellers), necessitating a "Majority of the Minority Vote." The filing provides crucial financial projections for Archenia and a fairness opinion, enabling shareholders to assess the strategic and financial merits of the deal before the July 1, 2026 Special Meeting.

At the time of this filing, MCHX was trading at $1.62 on NASDAQ in the Technology sector, with a market capitalization of approximately $71.8M. The 52-week trading range was $1.32 to $2.31. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MCHX - Latest Insights

MCHX
May 26, 2026, 4:35 PM EDT
Filing Type: PREM14A
Importance Score:
8
MCHX
May 14, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
MCHX
May 13, 2026, 4:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
MCHX
May 13, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
MCHX
May 12, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
MCHX
May 12, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
MCHX
Apr 17, 2026, 4:15 PM EDT
Filing Type: 10-K/A
Importance Score:
7
MCHX
Apr 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
MCHX
Mar 26, 2026, 8:45 AM EDT
Filing Type: 10-K
Importance Score:
8
MCHX
Mar 25, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8